Update on PrEP Impact trial in England
- Also published by:
- Department of Health
In response to stakeholders, Public Health England (PHE) and NHS England have published an update on the PrEP Impact Trial.
Two important meetings have taken place since our last update in June.
On 29 June, the trial’s Community Advisory Board met in London. The group is made up of representatives from community and voluntary groups representing people living with HIV and experts in HIV treatment and prevention.
The group was originally set up to provide PHE with advice around the co-ordination of an HIV-PrEP public health implementation pilot. The group agreed that, now a large scale trial was being set up, it would become more focussed on providing advice and assurance to the trial. As well as a discussion about its future role and membership, the group:
- received an update on progress with setting up the trial
- reviewed and commented on the communications plan for the trial
- made a number of suggestions about how to ensure the trial engages effectively with communities represented by members and also those communities that may be less engaged with services
On 14 July, the PrEP Programme Oversight Board met. The Board received an update on progress with the trial drug procurement - a number of bids had been received by the closing date and these were now being reviewed in advance of a preferred bidder being selected. Timescales were on track to appoint a supplier by the beginning of August.
The Board also received an assurance that the ethics committee approval was on track and that feedback on the trial budget had been addressed.
The Board reviewed and discussed plans to ensure the readiness of GUMclinics participating in the trial. It was accepted that some clinics would be ready to start providing PrEP sooner than others. However, members of the Board stressed the importance of ensuring that the first wave of participating clinics covered as wide a geographical area as possible and that other clinics came on stream as soon as possible afterwards.
Finally, the Board agreed a set of questions and answers to provide an update on trial progress to be sent out to stakeholders alongside the July stakeholder update. The list of questions and answers will be available on the trial website once it is operational. The next meeting of the Oversight Board is on 3 August and a further update will be provided in due course.
For further information on the trial, please contact email@example.com.
Latest News from
App that helps pregnant women monitor hypertension among new NHS innovations that will save lives and improve treatment23/11/2017 11:15:00
A wireless sensor that better detects breathing rate in hospital patients, an app to help pregnant women monitor hypertension and another that directs patients with minor injuries to treatment units with the shortest queues are among the latest innovations set to be spread across the NHS.
NHS England announces plans to break down barriers for research22/11/2017 12:15:00
NHS England yesterday announced plans to accelerate the NHS’ national research strategy, cutting bureaucracy and speeding up access to new and innovative treatments.
Black and ethnic minority cancer patients encouraged to give feedback on their NHS care22/11/2017 09:15:00
NHS England Chief Executive Simon Stevens today issued an appeal for more black and ethnic minority (BME) patients to help improve cancer care by sharing their experiences.
NHS England action to save lives by catching more cancers early21/11/2017 15:10:00
NHS England Chief Executive, Simon Stevens, will today announce the scaling up of an innovative scheme that catches lung cancer early by scanning patients, along with new details of a more sensitive bowel cancer test that could save thousands of lives.